Skip to Main Content

Author Details

Karin D Rodland
Oregon Health and Science University
1973
142
43
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36781807Use of Longitudinal Serum Analysis and Machine Learning to Develop a Classifier for Cancer Early Detection.Methods Mol Biol2023
37760474Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified Individuals.Cancers (Basel)2023
36653408A streamlined tandem tip-based workflow for sensitive nanoscale phosphoproteomics.Commun Biol2023
36781807Use of Longitudinal Serum Analysis and Machine Learning to Develop a Classifier for Cancer Early Detection.Methods Mol Biol2023
37760474Validation of a Proteomic Signature of Lung Cancer Risk from Bronchial Specimens of Risk-Stratified Individuals.Cancers (Basel)2023
36653408A streamlined tandem tip-based workflow for sensitive nanoscale phosphoproteomics.Commun Biol2023
34813325Evaluation of Differential Peptide Loading on Tandem Mass Tag-Based Proteomic and Phosphoproteomic Data Quality.J Am Soc Mass Spectrom2022
35654359New Views of Old Proteins: Clarifying the Enigmatic Proteome.Mol Cell Proteomics2022
35767427Internal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in Plasma.Anal Chem2022
35896960Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML.Clin Proteomics2022
36734985Oncoproteomic profiling of AML: moving beyond genomics.Expert Rev Proteomics2022
36536675A prognostic risk model for glioma patients by systematic evaluation of genomic variations.iScience2022
35213364Introduction to the special issue on Applications of Artificial Intelligence in Biomarker Research.Cancer Biomark2022
34813325Evaluation of Differential Peptide Loading on Tandem Mass Tag-Based Proteomic and Phosphoproteomic Data Quality.J Am Soc Mass Spectrom2022
35654359New Views of Old Proteins: Clarifying the Enigmatic Proteome.Mol Cell Proteomics2022
35767427Internal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in Plasma.Anal Chem2022
36536675A prognostic risk model for glioma patients by systematic evaluation of genomic variations.iScience2022
36734985Oncoproteomic profiling of AML: moving beyond genomics.Expert Rev Proteomics2022
35896960Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML.Clin Proteomics2022
35213364Introduction to the special issue on Applications of Artificial Intelligence in Biomarker Research.Cancer Biomark2022
32929967A Review of Imputation Strategies for Isobaric Labeling-Based Shotgun Proteomics.J Proteome Res2021
34171263The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance.Cancer Cell2021
33577785Proteogenomic and metabolomic characterization of human glioblastoma.Cancer Cell2021
34056417Assessment of TMT Labeling Efficiency in Large-Scale Quantitative Proteomics: The Critical Effect of Sample pH.ACS Omega2021
33671847Circulating Cancer Biomarkers.Cancers (Basel)2021
33649493Surfactant-assisted one-pot sample preparation for label-free single-cell proteomics.Commun Biol2021
34318300Antibody-Free Mass Spectrometry Identification of Vascular Integrity Markers in Major Trauma.Neurotrauma Rep2021
34351778Facile One-Pot Nanoproteomics for Label-Free Proteome Profiling of 50-1000 Mammalian Cells.J Proteome Res2021
32929967A Review of Imputation Strategies for Isobaric Labeling-Based Shotgun Proteomics.J Proteome Res2021
34407412CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance.Cell Rep2021
33649493Surfactant-assisted one-pot sample preparation for label-free single-cell proteomics.Commun Biol2021
33671847Circulating Cancer Biomarkers.Cancers (Basel)2021
33577785Proteogenomic and metabolomic characterization of human glioblastoma.Cancer Cell2021
34407412CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance.Cell Rep2021
34351778Facile One-Pot Nanoproteomics for Label-Free Proteome Profiling of 50-1000 Mammalian Cells.J Proteome Res2021
34318300Antibody-Free Mass Spectrometry Identification of Vascular Integrity Markers in Major Trauma.Neurotrauma Rep2021
34171263The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance.Cancer Cell2021
34056417Assessment of TMT Labeling Efficiency in Large-Scale Quantitative Proteomics: The Critical Effect of Sample pH.ACS Omega2021
32127492An Improved Boosting to Amplify Signal with Isobaric Labeling (iBASIL) Strategy for Precise Quantitative Single-cell Proteomics.Mol Cell Proteomics2020
32429558Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression.Cancers (Basel)2020
32127492An Improved Boosting to Amplify Signal with Isobaric Labeling (iBASIL) Strategy for Precise Quantitative Single-cell Proteomics.Mol Cell Proteomics2020
32825017Proteomic Analysis of Exosomes for Discovery of Protein Biomarkers for Prostate and Bladder Cancer.Cancers (Basel)2020
32532828Detection of Head and Neck Cancer Based on Longitudinal Changes in Serum Protein Abundance.Cancer Epidemiol Biomarkers Prev2020
32529193Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.Cell Rep Med2020
32954372Correction: Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.Cell Rep Med2020
32825017Proteomic Analysis of Exosomes for Discovery of Protein Biomarkers for Prostate and Bladder Cancer.Cancers (Basel)2020
32954372Correction: Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.Cell Rep Med2020
32529193Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.Cell Rep Med2020
32429558Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression.Cancers (Basel)2020
32532828Detection of Head and Neck Cancer Based on Longitudinal Changes in Serum Protein Abundance.Cancer Epidemiol Biomarkers Prev2020
  • 1 - 50 of 284

Recommended Authors

Brian L Hood
The Henry M. Jackson Foundation for the Advancement of Military Medicine
Career Start Year 2004
Number of shared co-authors 4
Jayantha Gunaratne
Institute of Molecular and Cell Biology
Career Start Year 2000
Number of shared co-authors 1
Kerby Shedden
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 4
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 3
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 1
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 6
Kaylene J Simpson
The University of Melbourne, Peter MacCallum Cancer Centre
Career Start Year 1996
Number of shared co-authors 0
Mu Wang
Academy of Pharmacy, Xi'an Jiaotong-Liverpool University
Career Start Year 1996
Number of shared co-authors 5
Jiefei Tong
Hospital for Sick Children
Career Start Year 1993
Number of shared co-authors 2
Jenny Xiang
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 2
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 7
Wenbin Wei
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year 1991
Number of shared co-authors 0
Abdel G Elkahloun
National Human Genome Research Institute
Career Start Year 1990
Number of shared co-authors 1
Emanuel F Petricoin
Center for Applied Proteomics and Molecular Medicine, George Mason University
Career Start Year 1988
Number of shared co-authors 15
David A Eberhard
Lineberger Comprehensive Cancer Center, University of North Carolina
Career Start Year 1987
Number of shared co-authors 4
Brent W Zanke
University of Toronto
Career Start Year 1987
Number of shared co-authors 0
Michael R Freeman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1987
Number of shared co-authors 1
Dean A Troyer
Eastern Virginia Medical School
Career Start Year 1985
Number of shared co-authors 9
Stephen R Pennington
UCD Conway Institute, University College Dublin
Career Start Year 1985
Number of shared co-authors 9
Michael F Moran
Hospital for Sick Children, University of Toronto
Career Start Year 1985
Number of shared co-authors 5
Oliver J Semmes
Eastern Virginia Medical School
Career Start Year 1985
Number of shared co-authors 10
David D L Bowtell
Peter MacCallum Cancer Centre
Career Start Year 1983
Number of shared co-authors 6
Astrid Laegreid
Norwegian University of Science and Technology
Career Start Year 1983
Number of shared co-authors 0
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 3
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 1
Eleftherios P Diamandis
Lunenfeld-Tanenbaum Research Institute
Career Start Year 1981
Number of shared co-authors 6
Samir M Hanash
University of Texas MD Anderson Cancer Center
Career Start Year 1977
Number of shared co-authors 16
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 6
Edouard C Nice
Monash University
Career Start Year 1971
Number of shared co-authors 11
John N Weinstein
The University of Texas MD Anderson Cancer Center
Career Start Year 1968
Number of shared co-authors 17

Collaborators

Richard D Smith
Pacific Northwest National Laboratory
Co-authored papers 58
Tao Liu
Pacific Northwest National Laboratory
Co-authored papers 50
Tujin Shi
Pacific Northwest National Laboratory
Co-authored papers 31
Wei-Jun Qian
Co-authored papers 28
Thomas L Fillmore
Pacific Northwest National Laboratory
Co-authored papers 21
Athena A Schepmoes
Pacific Northwest National Laboratory
Co-authored papers 19
Vladislav A Petyuk
Pacific Northwest National Laboratory
Co-authored papers 17
Marina A Gritsenko
Pacific Northwest National Laboratory
Co-authored papers 17
Jason E McDermott
Pacific Northwest National Laboratory
Co-authored papers 17
Sudhir Srivastava
National Cancer Institute
Co-authored papers 15
David G Camp
Co-authored papers 15
Henry Rodriguez
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers 14
Yuqian Gao
Co-authored papers 14
Rui Zhao
Co-authored papers 13
Chaochao Wu
Co-authored papers 12
Samuel H Payne
Brigham Young University
Co-authored papers 12
Daniel W Chan
Division of Clinical Chemistry, Johns Hopkins University
Co-authored papers 12
Paul D Piehowski
Pacific Northwest National Laboratory
Co-authored papers 12
Bobbie-Jo M Webb-Robertson
Pacific Northwest National Laboratory
Co-authored papers 11
Emily S Boja
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers 11
Ronald J Moore
Co-authored papers 11
Chia-Feng Tsai
Pacific Northwest National Laboratory
Co-authored papers 10
Christopher R Kinsinger
Co-authored papers 10
H S Wiley
Co-authored papers 9
Reid Townsend
Co-authored papers 9
Anil K Shukla
Pacific Northwest National Laboratory
Co-authored papers 9
Matthew E Monroe
Pacific Northwest National Laboratory
Co-authored papers 9
Zhen Zhang
Co-authored papers 9
Matthew J Ellis
Co-authored papers 9
Steven A Carr
Broad Institute of MIT and Harvard
Co-authored papers 8
Release 1.2